Table 4.
Effects of OLP-01 on Complete Blood Count Profiles.
| Characteristics | Before Intervention | After Intervention | ||
|---|---|---|---|---|
| Placebo | OLP-01 | Placebo | OLP-01 | |
| WBC (cells/mcL) | 7089 ± 471 | 7071 ± 320 | 7083 ± 487 | 7106 ± 456 |
| Neutrophils (%) | 51.7 ± 2.4 | 53.0 ± 2.8 | 51.9 ± 2.1 | 55.0 ± 2.4 |
| Lymphocytes (%) | 39.2 ± 2.2 | 36.7 ± 2.6 | 39.1 ± 2.2 | 35.3 ± 2.0 |
| Monocytes (%) | 5.5 ± 0.3 | 5.8 ± 0.4 | 5.8 ± 0.2 | 6.0 ± 0.3 |
| Eosinophil (%) | 2.9 ± 0.5 | 3.8 ± 1.0 | 2.4 ± 0.6 | 3.1 ± 0.5 |
| Basophil (%) | 0.7 ± 0.2 | 0.7 ± 0.1 | 0.8 ± 0.1 | 0.7 ± 0.1 |
| Platelet (103/mcL) | 252 ± 13 | 273 ± 15 | 271 ± 13 | 267 ± 11 |
| NLR | 1.39 ± 0.15 | 1.60 ± 0.25 | 1.40 ± 0.14 | 1.65 ± 0.17 |
| PLR | 96 ± 8 | 112 ± 10 | 102 ± 7 | 115 ± 11 |
Data are expressed as mean ± SEM. No significant differences between groups were found. NLR, ratio of neutrophil count to lymphocyte count; PLR, ratio of platelet count to lymphocyte count.